Age | Gender | Operation tecnique | Sample status * | Recurrent♣ | Tumour perforation | Metastatic | T | R | N | Serosa infiltration | Peretenoal carcino-matose | Time (months observed) | Status |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69 | M | LAR | primary | yes | yes | no | T3 | R0 | N0 | no | no | 26 | Dead |
64 | M | APR | primary | no | no | no | T3 | R0 | N2 | no | no | 39 | Dead |
76 | M | APR | primary | no | yes | no | T3 | R0 | N1 | no | no | 11 | Dead |
71 | K | Hartmann | local recurrent | no | no | no | unknown | R0 | Nx | yes | no | 19 | Dead |
61 | F | APR | local recurrent | no | no | no | unknown | R0 | Nx | no | no | 16 | Dead |
60 | F | LAR | primary | no | no | no | T3 | R0 | N1 | no | no | 15 | Alive |
77 | M | LAR | primary | no | no | no | T3 | R0 | N0 | no | no | 12 | Alive |
64 | F | LAR | primary | no | no | no | T3 | R0 | N2 | no | no | 11 | Alive |
49 | F | APR | primary | no | no | no | T3 | R0 | N2 | no | no | 4 | Alive |
60 | M | APR | primary | no | no | yes | T2 | R0 | N1 | no | no | 8 | Alive |
68 | M | LAR | primary | no | no | no | T2 | R0 | N0 | no | no | 3 | Alive |
71 | M | APR | primary | no | no | no | T3 | R0 | N0 | no | no | 3 | Alive |
61 | M | TumorRes | local recurrent | yes | yes | yes | unknown | R1 | Nx | no | no | 22 | Dead |
82 | M | APR | local recurrent | no | no | no | T4 | R1 | Nx | no | no | 18 | Alive |
59 | F | LAR | primary | no | no | no | T3 | R1 | N0 | possible | unsertain | 3 | Alive |
46 | K | Hartmann | primary | yes | yes | yes | T4 | R2 | N0 | no | yes | 21 | Alive |
66 | M | EksplLap | primary | yes | unknown | yes | T4 | R2 | Nx | unknown | yes | 1 | Dead |
69 | M | EksplLap | local recurrent | yes | no | no | unknown | R2 | unknown | no | no | 18 | Dead |
78 | M | Hartmann | local recurrent | yes | yes | no | T4 | R2 | Nx | no | no | 2 | Dead |